BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 27556938)

  • 1. Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala.
    Marcinkiewcz CA; Mazzone CM; D'Agostino G; Halladay LR; Hardaway JA; DiBerto JF; Navarro M; Burnham N; Cristiano C; Dorrier CE; Tipton GJ; Ramakrishnan C; Kozicz T; Deisseroth K; Thiele TE; McElligott ZA; Holmes A; Heisler LK; Kash TL
    Nature; 2016 Sep; 537(7618):97-101. PubMed ID: 27556938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for the extended amygdala in the fear-enhancing effects of acute selective serotonin reuptake inhibitor treatment.
    Ravinder S; Burghardt NS; Brodsky R; Bauer EP; Chattarji S
    Transl Psychiatry; 2013 Jan; 3(1):e209. PubMed ID: 23321806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-Dependent Modulation of Anxiety and Fear by 5-HT
    Marcinkiewcz CA; Bierlein-De La Rosa G; Dorrier CE; McKnight M; DiBerto JF; Pati D; Gianessi CA; Hon OJ; Tipton G; McElligott ZA; Delpire E; Kash TL
    ACS Chem Neurosci; 2019 Jul; 10(7):3154-3166. PubMed ID: 31140276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in circuits activated by corticotropin releasing factor in rats.
    Salvatore M; Wiersielis KR; Luz S; Waxler DE; Bhatnagar S; Bangasser DA
    Horm Behav; 2018 Jan; 97():145-153. PubMed ID: 29037972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended Amygdala to Ventral Tegmental Area Corticotropin-Releasing Factor Circuit Controls Binge Ethanol Intake.
    Rinker JA; Marshall SA; Mazzone CM; Lowery-Gionta EG; Gulati V; Pleil KE; Kash TL; Navarro M; Thiele TE
    Biol Psychiatry; 2017 Jun; 81(11):930-940. PubMed ID: 27113502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRF-5-HT interactions in the dorsal raphe nucleus and motivation for stress-induced opioid reinstatement.
    Li C; McCloskey N; Phillips J; Simmons SJ; Kirby LG
    Psychopharmacology (Berl); 2021 Jan; 238(1):29-40. PubMed ID: 33231727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization.
    Huang MM; Overstreet DH; Knapp DJ; Angel R; Wills TA; Navarro M; Rivier J; Vale W; Breese GR
    J Pharmacol Exp Ther; 2010 Jan; 332(1):298-307. PubMed ID: 19843974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amygdalar corticotropin-releasing factor mediates stress-induced anxiety.
    Ventura-Silva AP; Borges S; Sousa N; Rodrigues AJ; Pêgo JM
    Brain Res; 2020 Feb; 1729():146622. PubMed ID: 31881185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optogenetic silencing of a corticotropin-releasing factor pathway from the central amygdala to the bed nucleus of the stria terminalis disrupts sustained fear.
    Asok A; Draper A; Hoffman AF; Schulkin J; Lupica CR; Rosen JB
    Mol Psychiatry; 2018 Apr; 23(4):914-922. PubMed ID: 28439099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons.
    Kirby LG; Freeman-Daniels E; Lemos JC; Nunan JD; Lamy C; Akanwa A; Beck SG
    J Neurosci; 2008 Nov; 28(48):12927-37. PubMed ID: 19036986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History.
    Snyder KP; Hill-Smith TE; Lucki I; Valentino RJ
    Neuropsychopharmacology; 2015 Oct; 40(11):2517-25. PubMed ID: 25865931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic effects of selective serotonin reuptake inhibitor treatment on fear conditioning: implications for underlying fear circuits.
    Burghardt NS; Bauer EP
    Neuroscience; 2013 Sep; 247():253-72. PubMed ID: 23732229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety.
    Sink KS; Walker DL; Freeman SM; Flandreau EI; Ressler KJ; Davis M
    Mol Psychiatry; 2013 Mar; 18(3):308-19. PubMed ID: 22290119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A corticotropin releasing factor pathway for ethanol regulation of the ventral tegmental area in the bed nucleus of the stria terminalis.
    Silberman Y; Matthews RT; Winder DG
    J Neurosci; 2013 Jan; 33(3):950-60. PubMed ID: 23325234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crh receptor priming in the bed nucleus of the stria terminalis (BNST) induces tph2 gene expression in the dorsomedial dorsal raphe nucleus and chronic anxiety.
    Donner NC; Davies SM; Fitz SD; Kienzle DM; Shekhar A; Lowry CA
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109730. PubMed ID: 31415826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dorsal raphe serotonin neurons inhibit operant responding for reward via inputs to the ventral tegmental area but not the nucleus accumbens: evidence from studies combining optogenetic stimulation and serotonin reuptake inhibition.
    Browne CJ; Abela AR; Chu D; Li Z; Ji X; Lambe EK; Fletcher PJ
    Neuropsychopharmacology; 2019 Mar; 44(4):793-804. PubMed ID: 30420603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex dependent reduction by prenatal stress of the expression of 5HT1A receptors in the prefrontal cortex and CRF type 2 receptors in the raphe nucleus in rats: reversal by citalopram.
    Zohar I; Dosoretz-Abittan L; Shoham S; Weinstock M
    Psychopharmacology (Berl); 2015 May; 232(9):1643-53. PubMed ID: 25420605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-type specific deletion of GABA(A)α1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction.
    Gafford GM; Guo JD; Flandreau EI; Hazra R; Rainnie DG; Ressler KJ
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16330-5. PubMed ID: 22992651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Fenfluramine induces serotonin-mediated Fos expression in corticotropin-releasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala.
    Javed A; Kamradt MC; Van de Kar LD; Gray TS
    Neuroscience; 1999 Mar; 90(3):851-8. PubMed ID: 10218785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA and NMDA receptors in CRF neurons have opposing effects in fear acquisition and anxiety in central amygdala vs. bed nucleus of the stria terminalis.
    Gafford GM; Ressler KJ
    Horm Behav; 2015 Nov; 76():136-42. PubMed ID: 25888455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.